Pasar al contenido principal

REGULACION POR VRK1 DE REMODELACION DE CROMATINA EN LA PATOGENESIS DEL CANCER Y NEURODEGERACION

PID2019-105610RB-I00

•
Nombre agencia financiadora Agencia Estatal de Investigación
Acrónimo agencia financiadora AEI
Programa Programa Estatal de I+D+i Orientado a los Retos de la Sociedad
Convocatoria Proyectos de I+D+i (Generación de Conocimiento y Retos Investigación)
Año convocatoria 2019
Plan Estatal 2017-2020 Plan Estatal de Investigación Científica y Técnica y de Innovación
Centro beneficiario AGENCIA ESTATAL CONSEJO SUPERIOR DE INVESTIGACIONES CIENTIFICAS (CSIC)

Resultados relacionados

Resultados totales (Incluyendo duplicados): 16
Encontrada(s) 1 página(s)

DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Novel dominant KCNQ2 exon 7 partial in-frame duplication in a complex epileptic and neurodevelopmental delay syndrome

  • Lazo, Pedro A.
  • García, Juan L.
  • Gómez-Puertas, Paulino
  • Marcos-Alcalde, Íñigo
  • Arjona, César
  • Villarroel, Álvaro
  • González-Sarmiento, Rogelio
  • Fons, Carmen
Complex neurodevelopmental syndromes frequently have an unknown etiology, in which genetic factors play a pathogenic role. This study utilizes whole-exome sequencing (WES) to examine four members of a family with a son presenting, since birth, with epileptic-like crises, combined with cerebral palsy, severe neuromotor and developmental delay, dystonic tetraparexia, axonal motor affectation, and hyper-excitability of unknown origin. The WES study detected within the patient a de novo heterozygous in-frame duplication of thirty-six nucleotides within exon 7 of the human KCNQ2 gene. This insertion duplicates the first twelve amino acids of the calmodulin binding site I. Molecular dynamics simulations of this KCNQ2 peptide duplication, modelled on the 3D structure of the KCNQ2 protein, suggest that the duplication may lead to the dysregulation of calcium inhibition of this protein function., Grants from Agencia Estatal de Investigación-Ministerio de Economía y Competitividad-FEDER-Fondo Social Europeo (SAF2016-75744-R, PID2019-105610RB-I00) and Consejería de Educación-Junta de Castilla y León (CLC-2017-01 and UIC-258) to P.A.L. Ministerio de Economía, Industria y Competitividad (CTQ2015-68756-R, BFU2015-66910-R) to A.V. Ministerio de Economía y Competitividad-Fondo Social Europeo Grant from Instituto de Salud Carlos III-Fondo Social Europeo (PI16/01920) to R. G-S. Agencia Estatal de Investigación-Ministerio de Economía y Competitividad-FEDER-Fondo Social Europeo (RTC-2017-6494-1 and RTI2018-094434-B-I00) to P. G-P. Financial support of the Departament de Salut de la Generalitat de Catalunya-URDCat Project (SLT002/16/00174) to C.A. and C.F., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

VRK1 phosphorylates Tip60/KAT5 and is required for H4K16 acetylation in response to DNA damage

  • García González, Raúl
  • Morejón-García, Patricia
  • Campillo-Marcos, Ignacio
  • Salzano, Marcella
Dynamic remodeling of chromatin requires acetylation and methylation of histones, frequently affecting the same lysine residue. These alternative epigenetic modifications require the coordination of enzymes, writers and erasers, mediating them such as acetylases and deacetylases. In cells in G0/G1, DNA damage induced by doxorubicin causes an increase in histone H4K16ac, a marker of chromatin relaxation. In this context, we studied the role that VRK1, a chromatin kinase activated by DNA damage, plays in this early step. VRK1 depletion or MG149, a Tip60/KAT5 inhibitor, cause a loss of H4K16ac. DNA damage induces the phosphorylation of Tip60 mediated by VRK1 in the chromatin fraction. VRK1 directly interacts with and phosphorylates Tip60. Furthermore, the phosphorylation of Tip60 induced by doxorubicin is lost by depletion of VRK1 in both ATM +/+ and ATM−/− cells. Kinase-active VRK1, but not kinase-dead VRK1, rescues Tip60 phosphorylation induced by DNA damage independently of ATM. The Tip60 phosphorylation by VRK1 is necessary for the activating acetylation of ATM, and subsequent ATM autophosphorylation, and both are lost by VRK1 depletion. These results support that the VRK1 chromatin kinase is an upstream regulator of the initial acetylation of histones, and an early step in DNA damage responses (DDR)., This work was supported by grants from Agencia Estatal de Investigación-Ministerio de Economía y Competitividad-FEDER [SAF2016-75744-R; RED2018-102801-T, PID2019-105610RB-I00] Consejería de Educación de la Junta de Castilla y León-ERDF [CLC-2017-01, and UIC-258] to P.A.L., R.G.-G, P.M.-G. and I.C.-M. were supported by Consejería de Educación-Junta de Castilla y León-Fondo Social Europeo (ESF), Ministerio de Educación y Universidades [FPU 16-01883] and MINECO-FPI [BES-2014-067729] predoctoral fellowships respectively.
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Pathogenic convergence of CNVs in genes functionally associated to a severe neuromotor developmental delay syndrome

  • García-Hernández, Juan L.
  • Corchete, Luis A.
  • Marcos-Alcalde, Íñigo
  • Gómez-Puertas, Paulino
  • Fons, Carmen
  • Lazo, Pedro A.
© The Author(s)., [Background]: Complex developmental encephalopathy syndromes might be the consequence of unknown genetic alterations that are likely to contribute to the full neurological phenotype as a consequence of pathogenic gene combinations. [Methods]: To identify the additional genetic contribution to the neurological phenotype, we studied as a test case a boy, with a KCNQ2 exon-7 partial duplication, by single-nucleotide polymorphism (SNP) microarray to detect copy-number variations (CNVs). [Results]: The proband presented a cerebral palsy like syndrome with a severe motor and developmental encephalopathy. The SNP array analysis detected in the proband several de novo CNVs, nine partial gene losses (LRRC55, PCDH9, NALCN, RYR3, ELAVL2, CDH13, ATP1A2, SLC17A5, ANO3), and two partial gene duplications (PCDH19, EFNA5). The biological functions of these genes are associated with ion channels such as calcium, chloride, sodium, and potassium with several membrane proteins implicated in neural cell-cell interactions, synaptic transmission, and axon guidance. Pathogenically, these functions can be associated to cerebral palsy, seizures, dystonia, epileptic crisis, and motor neuron dysfunction, all present in the patient. [Conclusions]: Severe motor and developmental encephalopathy syndromes of unknown origin can be the result of a phenotypic convergence by combination of several genetic alterations in genes whose physiological function contributes to the neurological pathogenic mechanism., Grants from Agencia Estatal de Investigación, Ministerio de Ciencia e Innovación (SAF2016-75744-R, PID2019-105610RB-I00) and Consejería de Educación-Junta de Castilla y León (CSI264P20, CLC-2017-01, and UIC-258) to P.A.L. Agencia Estatal de Investigación-Ministerio de Economía y Competitividad-FEDER-Fondo Social Europeo (RTC-2017-6494-1 and RTI2018-094434-B-I00) to P. G-P. Departament de Salut de la Generalitat de Catalunya-URDCat Project (SLT002/16/00174) to C.F.
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Dysfunctional Homozygous VRK1-D263G Variant Impairs the Assembly of Cajal Bodies and DNA Damage Response in Hereditary Spastic Paraplegia

  • Morejón-García, Patricia
  • Keren, Boris
  • Marcos-Alcalde, Íñigo
  • Gómez-Puertas, Paulino
  • Mochel, Fanny
  • Lazo, Pedro A.
[Background and Objectives]: To conduct a genetic and molecular functional study of a family with members affected of hereditary spastic paraplegia (HSP) of unknown origin and carrying a novel pathogenic vaccinia-related kinase 1 (VRK1) variant., [Methods]: Whole-exome sequencing was performed in 2 patients, and their parents diagnosed with HSP. The novel VRK1 variant was detected by whole-exome sequencing, molecularly modeled and biochemically characterized in kinase assays. Functionally, we studied the role of this VRK1 variant in DNA damage response and its effect on the assembly of Cajal bodies (CBs)., [Results]: We have identified a very rare homozygous variant VRK1-D263G with a neurologic phenotype associated with HSP and moderate intellectual disability. The molecular modeling of this VRK1 variant protein predicted an alteration in the folding of a loop that interferes with the access to the kinase catalytic site. The VRK1-D263G variant is kinase inactive and does not phosphorylate histones H2AX and H3, transcription factors activating transcription factor 2 and p53, coilin needed for assembly of CBs, and p53 binding protein 1, a DNA repair protein. Functionally, this VRK1 variant protein impairs CB formation and the DNA damage response., [Discussion]: This report expands the neurologic spectrum of neuromotor syndromes associated with a new and rare VRK1 variant, representing a novel pathogenic participant in complicated HSP and demonstrates that CBs and the DNA damage response are impaired in these patients., P. M-G. was supported by Ministerio de Educación-FPU predoctoral fellowship (FPU16/01883). This work was funded by grants from Agencia Estatal de Investigaci´on/ Ministerio de Ciencia e Innovaci´on (PID2019-105610RBI00) and Consejería de Educación-Junta de Castilla y León (CSI264P20) to P.A.L. Agencia Estatal de Investigaci´onMinisterio de Ciencia, Innovaci´on y Universidades (RTC2017-6494-1 and RTI2018-094434-B-I00) and European Commission project “CONNECT-JPIAMR Virtual Research Institute” to P.G-P. The Instituto de Biolog´ıa Molecular y Celular del Cancer is funded by a grant from Junta de Castilla y León-FEDER (CLC-2017-01).
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Lysine methyltransferase inhibitors impair H4K20me2 and 53BP1 foci in response to DNA damage in sarcomas, a synthetic lethality strategy

  • Campillo-Marcos, Ignacio
  • Monte-Serrano, Eva
  • Navarro Carrasco, Elena
  • García González, Raúl
  • Lazo, Pedro A.
© 2021 Campillo-Marcos, Monte-Serrano, Navarro-Carrasco, García-González and Lazo., [Background]: Chromatin is dynamically remodeled to adapt to all DNA-related processes, including DNA damage responses (DDR). This adaptation requires DNA and histone epigenetic modifications, which are mediated by several types of enzymes; among them are lysine methyltransferases (KMTs)., [Methods]: KMT inhibitors, chaetocin and tazemetostat (TZM), were used to study their role in the DDR induced by ionizing radiation or doxorubicin in two human sarcoma cells lines. The effect of these KMT inhibitors was tested by the analysis of chromatin epigenetic modifications, H4K16ac and H4K20me2. DDR was monitored by the formation of γH2AX, MDC1, NBS1 and 53BP1 foci, and the induction of apoptosis., [Results]: Chaetocin and tazemetostat treatments caused a significant increase of H4K16 acetylation, associated with chromatin relaxation, and increased DNA damage, detected by the labeling of free DNA-ends. These inhibitors significantly reduced H4K20 dimethylation levels in response to DNA damage and impaired the recruitment of 53BP1, but not of MDC1 and NBS1, at DNA damaged sites. This modification of epigenetic marks prevents DNA repair by the NHEJ pathway and leads to cell death., [Conclusion]: KMT inhibitors could function as sensitizers to DNA damage-based therapies and be used in novel synthetic lethality strategies for sarcoma treatment., IC-M was supported by FPI-MINECO-FSE contract (BES-2014-067721). EM-S was funded by Consejería de Educación-Junta de Castilla y León (CSI004-18). EN-C was funded by FPI-MINECO-FSE contract (BES-2017-080543). RG-G was supported by Consejería de Educación-Junta de Castilla y León. This work was supported by grants from Agencia Estatal de Investigación-Ministerio de Ciencia, Innovación y Universidades-FEDER (SAF2016-75744-R, PID2019-105610RB-I00), and Consejería de Educación de la Junta de Castilla y León (CSI264P20, CLC-2017-01) to PL.
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

The human VRK1 chromatin kinase in cancer biology

  • Campillo-Marcos, Ignacio
  • García González, Raúl
  • Navarro Carrasco, Elena
  • Lazo, Pedro A.
© 2021 The Authors., VRK1 is a nuclear Ser-Thr chromatin kinase that does not mutate in cancer, and is overexpressed in many types of tumors and associated with a poor prognosis. Chromatin VRK1 phosphorylates several transcription factors, including p53, histones and proteins implicated in DNA damage response pathways. In the context of cell proliferation, VRK1 regulates entry in cell cycle, chromatin condensation in G2/M, Golgi fragmentation, Cajal body dynamics and nuclear envelope assembly in mitosis. This kinase also controls the initial chromatin relaxation associated with histone acetylation, and the non-homologous-end joining (NHEJ) DNA repair pathway, which involves sequential steps such as γH2AX, NBS1 and 53BP1 foci formation, all phosphorylated by VRK1, in response to ionizing radiation or chemotherapy. In addition, VRK1 can be an alternative target for therapies based on synthetic lethality strategies. Therefore, VRK1 roles on proliferation have a pro-tumorigenic effect. Functions regulating chromatin stability and DNA damage responses have a protective anti-tumor role in normal cells, but in tumor cells can also facilitate resistance to genotoxic treatments., The laboratory was funded by grants from Agencia Estatal de Investigación-Ministerio de Ciencia e Innovacion (SAF2016-75744-R, PID2019-105610RB-I00) and Consejería de Educación-Junta de Castilla y León-FEDER (CSI264P20, CLC-2017-01 and UIC-258). I.C-M and E. N–C were supported by FPI-MINECO-Agencia Estatal de Investigación predoctoral contracts (BES-2014-06772, BES-2017-080543) respectively. R. G-G. was supported by a predoctoral contract from Consejería de Educación-Junta de Castilla y León-FEDER.
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

VRK1 depletion facilitates the synthetic lethality of temozolomide and olaparib in glioblastoma cells

  • Navarro Carrasco, Elena
  • Lazo, Pedro A.
© 2021 Navarro-Carrasco and Lazo., [Background]: Glioblastomas treated with temozolomide frequently develop resistance to pharmacological treatments. Therefore, there is a need to find alternative drug targets to reduce treatment resistance based on tumor dependencies. A possibility is to target simultaneously two proteins from different DNA-damage repair pathways to facilitate tumor cell death. Therefore, we tested whether targeting the human chromatin kinase VRK1 by RNA interference can identify this protein as a novel molecular target to reduce the dependence on temozolomide in combination with olaparib, based on synthetic lethality., [Materials and Methods]: Depletion of VRK1, an enzyme that regulates chromatin dynamic reorganization and facilitates resistance to DNA damage, was performed in glioblastoma cells treated with temozolomide, an alkylating agent used for GBM treatment; and olaparib, an inhibitor of PARP-1, used as sensitizer. Two genetically different human glioblastoma cell lines, LN-18 and LN-229, were used for these experiments. The effect on the DNA-damage response was followed by determination of sequential steps in this process: H4K16ac, γH2AX, H4K20me2, and 53BP1., [Results]: The combination of temozolomide and olaparib increased DNA damage detected by labeling free DNA ends, and chromatin relaxation detected by H4K16ac. The combination of both drugs, at lower doses, resulted in an increase in the DNA damage response detected by the formation of γH2AX and 53BP1 foci. VRK1 depletion did not prevent the generation of DNA damage in TUNEL assays, but significantly impaired the DNA damage response induced by temozolomide and olaparib, and mediated by γH2AX, H4K20me2, and 53BP1. The combination of these drugs in VRK1 depleted cells resulted in an increase of glioblastoma cell death detected by annexin V and the processing of PARP-1 and caspase-3., [Conclusion]: Depletion of the chromatin kinase VRK1 promotes tumor cell death at lower doses of a combination of temozolomide and olaparib treatments, and can be a novel alternative target for therapies based on synthetic lethality., EN-C was supported by FPI-MINECO-Agencia Estatal de Investigación contract (BES-2017-080543). The laboratory was supported by grants from Agencia Estatal de Investigación-Ministerio de Ciencia e Innovacion (SAF2016-75744-R, PID2019-105610RB-I00) and Consejería de Educación-Junta de Castilla y León-FEDER (CSI264P20, CLC-2017-01) to PL.
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Targeting histone epigenetic modifications and DNA damage responses in synthetic lethality strategies in cancer?

  • Lazo, Pedro A.
Synthetic lethality strategies are likely to be integrated in effective and specific cancer treatments. These strategies combine different specific targets, either in similar or cooperating pathways. Chromatin remodeling underlies, directly or indirectly, all processes of tumor biology. In this context, the combined targeting of proteins associated with different aspects of chromatin remodeling can be exploited to find new alternative targets or to improve treatment for specific individual tumors or patients. There are two major types of proteins, epigenetic modifiers of histones and nuclear or chromatin kinases, all of which are druggable targets. Among epigenetic enzymes, there are four major families: histones acetylases, deacetylases, methylases and demethylases. All these enzymes are druggable. Among chromatin kinases are those associated with DNA damage responses, such as Aurora A/B, Haspin, ATM, ATR, DNA-PK and VRK1—a nucleosomal histone kinase. All these proteins converge on the dynamic regulation chromatin organization, and its functions condition the tumor cell viability. Therefore, the combined targeting of these epigenetic enzymes, in synthetic lethality strategies, can sensitize tumor cells to toxic DNA-damage-based treatments, reducing their toxicity and the selective pressure for tumor resistance and increasing their immunogenicity, which will lead to an improvement in disease-free survival and quality of life., P.A.L. was supported by grants from Agencia Estatal de Investigación (doi:10.13039/501100011033)-Ministerio de Ciencia e Innovación-FEDER (PID2019-105610RB-I00, RED2018-102801-T) and Consejería de Educación de la Junta de Castilla y León-FEDER (CSI264P20, CLC-2017-01).
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

The VRK1 chromatin kinase regulates the acetyltransferase activity of Tip60/KAT5 by sequential phosphorylations in response to DNA damage

  • García González, Raúl
  • Monte-Serrano, Eva
  • Morejón-García, Patricia
  • Navarro Carrasco, Elena
  • Lazo, Pedro A.
The regulation of histone epigenetic modifications mediates the adaptation of chromatin to different biological processes. DNA damage causes a local relaxation of chromatin associated to histone H4 acetylation in K16, mediated by Tip60/KAT5. In this work, we have studied the role that the VRK1 chromatin kinase plays on the activation of Tip60 during this process. In the DNA damage response induced by doxorubicin, VRK1 directly phosphorylates Tip60. However, the phosphorylated Tip60 residues and their functional roles are unknown. In DDR, we have identified these two Tip60 phosphorylated residues and the cooperation of the participating kinases. The T158 phosphorylation, mediated by VRK1, is early and transient, preceding that of S199, which is more sustained in time, and mediated by DNA-PK. The role of each phosphorylated residues was determined by using phosphomimetic and phosphonull mutants and their combination. T158 phosphorylation protects Tip60 from ubiquitin-mediated degradation, promotes its recruitment to chromatin from the nucleoplasm, and is necessary for its full trans-acetylase activity. The phosphorylation in S199 by DNA-PK directly facilitates Tip60 autoacetylation, but it is not enough for trans-acetylation of two of its targets, histone H4 and ATM, which requires a double phosphorylation of Tip60 in T158 and S199. DNA-PK inhibitors block the phosphorylation of S199. We propose a model in which the cooperation between VRK1 and DNA-PK mediates the sequential phosphorylation of Tip60/KAT5, and contributes to the recruitment of this protein to initiate the sequential remodeling of chromatin in DDR. Both proteins are candidates for novel synthetic lethality strategies in cancer treatment., This work was supported by grants from Agencia Estatal de Investigación (doi: 10.13039/501100011033) - Ministerio de Ciencia e Innovación-FEDER (RED2018-102801-T, PID2019-105610RB-I00), Consejería de Educación de la Junta de Castilla y León-ERDF (CSI264P20, CLC-2017-01) to P.A.L. P. M.-G. was supported by Ministerio de Educación predoctoral fellowship (FPU16/01883). R. G-G and E. M-S. were supported (Consejería de Educación-Junta de Castilla y León-Fondo Social Europeo (CSI004-18), predoctoral fellowships respectively. E. N-C was supported by Agencia Estatal de Investigación-MINECO predoctoral fellowship (BES-2017-080543).
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

VRK1 Kinase Activity Modulating Histone H4K16 Acetylation Inhibited by SIRT2 and VRK-IN-1

  • Monte-Serrano, Eva
  • Lazo, Pedro A.
The accessibility of DNA to different cellular functions requires a dynamic regulation of chromatin organization that is mediated by different epigenetic modifications, which regulate chromatin accessibility and degree of compaction. These epigenetic modifications, particularly the acetylation of histone H4 in lysine 14 (H4K16ac), determine the degree of chromatin accessibility to different nuclear functions, as well as to DNA damage drugs. H4K16ac is regulated by the balance between two alternative histone modifications, acetylation and deacetylation, which are mediated by acetylases and deacetylases. Tip60/KAT5 acetylates, and SIRT2 deacetylates histone H4K16. However, the balance between these two epigenetic enzymes is unknown. VRK1 regulates the level of H4K16 acetylation by activating Tip60. We have shown that the VRK1 and SIRT2 are able to form a stable protein complex. For this work, we used in vitro interaction, pull-down and in vitro kinase assays. In cells, their interaction and colocalization were detected by immunoprecipitation and immunofluorescence. The kinase activity of VRK1 is inhibited by a direct interaction of its N-terminal kinase domain with SIRT2 in vitro. This interaction causes a loss of H4K16ac similarly to the effect of a novel VRK1 inhibitor (VRK-IN-1) or VRK1 depletion. The use of specific SIRT2 inhibitors in lung adenocarcinoma cells induces H4K16ac, contrary to the novel VRK-IN-1 inhibitor, which prevents H4K16ac and a correct DNA damage response. Therefore, the inhibition of SIRT2 can cooperate with VRK1 in the accessibility of drugs to chromatin in response to DNA damage caused by doxorubicin., This research was funded by grants from Agencia Estatal de Investigación (doi: 10.13039/501100011033)–Ministerio de Ciencia e Innovación–“FEDER: Una manera de hacer Europa” (PID2019-105610RB-I00, RED2018-102801-T), Consejería de Educación de la Junta de Castilla y León–FEDER (CSI264P20, CLC-2017-01) to P.A.L. Predoctoral contract to E. M-S from Consejería de Educación–Junta de Castilla y León–Fondo Social Europeo (CSI004-18)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

The pattern of histone H3 epigenetic posttranslational modifications is regulated by the VRK1 chromatin kinase

  • Monte-Serrano, Eva
  • Morejón-García, Patricia
  • Campillo-Marcos, Ignacio
  • Campos Díaz, Aurora
  • Navarro Carrasco, Elena
  • Lazo, Pedro A.
[Background]: Dynamic chromatin remodeling is associated with changes in the epigenetic pattern of histone acetylations and methylations required for processes based on dynamic chromatin remodeling and implicated in different nuclear functions. These histone epigenetic modifications need to be coordinated, a role that may be mediated by chromatin kinases such as VRK1, which phosphorylates histones H3 and H2A., [Methods]: The effect of VRK1 depletion and VRK1 inhibitor, VRK-IN-1, on the acetylation and methylation of histone H3 in K4, K9 and K27 was determined under different conditions, arrested or proliferating cells, in A549 lung adenocarcinoma and U2OS osteosarcoma cells., [Results]: Chromatin organization is determined by the phosphorylation pattern of histones mediated by different types of enzymes. We have studied how the VRK1 chromatin kinase can alter the epigenetic posttranslational modifications of histones by using siRNA, a specific inhibitor of this kinase (VRK-IN-1), and of histone acetyl and methyl transferases, as well as histone deacetylase and demethylase. Loss of VRK1 implicated a switch in the state of H3K9 posttranslational modifications. VRK1 depletion/inhibition causes a loss of H3K9 acetylation and facilitates its methylation. This effect is similar to that of the KAT inhibitor C646, and to KDM inhibitors as iadademstat (ORY-1001) or JMJD2 inhibitor. Alternatively, HDAC inhibitors (selisistat, panobinostat, vorinostat) and KMT inhibitors (tazemetostat, chaetocin) have the opposite effect of VRK1 depletion or inhibition, and cause increase of H3K9ac and a decrease of H3K9me3. VRK1 stably interacts with members of these four enzyme families. However, VRK1 can only play a role on these epigenetic modifications by indirect mechanisms in which these epigenetic enzymes are likely targets to be regulated and coordinated by VRK1., [Conclusions]: The chromatin kinase VRK1 regulates the epigenetic patterns of histone H3 acetylation and methylation in lysines 4, 9 and 27. VRK1 is a master regulator of chromatin organization associated with its specific functions, such as transcription or DNA repair., This work was supported by grants from Agencia Estatal de Investigación (https://doi.org/10.13039/501100011033) AEI/Ministerio de Ciencia e Innovación-“FEDER Una manera de hacer Europa” (PID2019-105610RB-I00, RED2018-102801-T), and Consejería de Educación de la Junta de Castilla y León-FEDER (CSI264P20, CLC-2017-01) to P. A. L. E. M.-S was funded by predoctoral contract (CSI004-18) from Consejería de Educación-Junta de Castilla y León-Fondo Social Europeo (FSE). Ministerio de Educación-FSE predoctoral FPU contracts funded P. M.-G. (FPU16/01883) and A. C.-D. (FPU20/02978). I.C.-M. was supported by FPI-MINECO-FSE contract (BES-2014-067721). E. N-C. was funded by Agencia Estatal de Investigación-MINECO predoctoral contract (BES-2017-080543)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

VRK1 Regulates Sensitivity to Oxidative Stress by Altering Histone Epigenetic Modifications and the Nuclear Phosphoproteome in Tumor Cells

  • Navarro Carrasco, Elena
  • Monte-Serrano, Eva
  • Campos Díaz, Aurora
  • Rolfs, Frank
  • Goeij-de Haas, Richard de
  • Pham, Thang V.
  • Piersma, Sander R.
  • Gonzalez-Alonso, Paula
  • Jiménez, Connie R.
  • Lazo, Pedro A.
© 2024 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/)., The chromatin organization and its dynamic remodeling determine its accessibility and sensitivity to DNA damage oxidative stress, the main source of endogenous DNA damage. We studied the role of the VRK1 chromatin kinase in the response to oxidative stress. which alters the nuclear pattern of histone epigenetic modifications and phosphoproteome pathways. The early effect of oxidative stress on chromatin was studied by determining the levels of 8-oxoG lesions and the alteration of the epigenetic modification of histones. Oxidative stress caused an accumulation of 8-oxoG DNA lesions that were increased by VRK1 depletion, causing a significant accumulation of DNA strand breaks detected by labeling free 3′-DNA ends. In addition, oxidative stress altered the pattern of chromatin epigenetic marks and the nuclear phosphoproteome pathways that were impaired by VRK1 depletion. Oxidative stress induced the acetylation of H4K16ac and H3K9 and the loss of H3K4me3. The depletion of VRK1 altered all these modifications induced by oxidative stress and resulted in losses of H4K16ac and H3K9ac and increases in the H3K9me3 and H3K4me3 levels. All these changes were induced by the oxidative stress in the epigenetic pattern of histones and impaired by VRK1 depletion, indicating that VRK1 plays a major role in the functional reorganization of chromatin in the response to oxidative stress. The analysis of the nuclear phosphoproteome in response to oxidative stress detected an enrichment of the phosphorylated proteins associated with the chromosome organization and chromatin remodeling pathways, which were significantly decreased by VRK1 depletion. VRK1 depletion alters the histone epigenetic pattern and nuclear phosphoproteome pathways in response to oxidative stress. The enzymes performing post-translational epigenetic modifications are potential targets in synthetic lethality strategies for cancer therapies., This work was funded by grants to P.A.L. from Agencia Estatal de Investigación (doi: 10.13039/501100011033)-Ministerio de Ciencia e Innovación-FEDER “Una manera de hacer Europa” (PID2019-105610RB-I00, PID2022-139598OB-I00), Consejería de Educación de la Junta de Castilla y León-FEDER (CSI264P20). E.N.-C. was funded by Agencia Estatal de Investigación-MINECO predoctoral contract (BES-2017-080543) and EMBO Scientific Exchange Grant (9289). E.M.-S. was funded by a predoctoral contract (CSI004-18) from Consejería de Educación-Junta de Castilla y León-Fondo Social Europeo. A.C.-D. was funded by Ministerio de Universidades-FSE predoctoral FPU contract (FPU20/02978). Cancer Center Amsterdam and Netherlands Organization for Scientific Research (NOW-Middelgroot project number 91116017) are acknowledged for support of the mass spectrometry infrastructure, and Surfsara for computing infrastructure (reference e-infra180166) to C.R.J., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Loss of VRK1 alters the nuclear phosphoproteome in the DNA damage response to doxorubicin

  • Navarro Carrasco, Elena
  • Campos Díaz, Aurora
  • Monte-Serrano, Eva
  • Rolfs, Frank
  • Goeij-de Haas, Richard de
  • Pham, Thang V.
  • Piersma, Sander R.
  • Jiménez, Connie R.
  • Lazo, Pedro A.
Dynamic chromatin remodeling requires regulatory mechanisms for its adaptation to different nuclear function, which are likely to be mediated by signaling proteins. In this context, VRK1 is a nuclear Ser-Thr kinase that regulates pathways associated with transcription, replication, recombination, and DNA repair. Therefore, VRK1 is a potential regulatory, or coordinator, molecule in these processes. In this work we studied the effect that VRK1 depletion has on the basal nuclear and chromatin phosphoproteome, and their associated pathways. VRK1 depletion caused an alteration in the pattern of the nuclear phosphoproteome, which is mainly associated with nucleoproteins, ribonucleoproteins, RNA splicing and processing. Next, it was determined the changes in proteins associated with DNA damage that was induced by doxorubicin treatment. Doxorubicin alters the nuclear phosphoproteome affecting proteins implicated in DDR, including DSB repair proteins NBN and 53BP1, cellular response to stress and chromatin organization proteins. In VRK1-depleted cells, the effect of doxorubicin on protein phosphorylation was reverted to basal levels. The nuclear phosphoproteome patterns induced by doxorubicin are altered by VRK1 depletion, and is enriched in histone modification proteins and chromatin associated proteins. These results indicate that VRK1 plays a major role in processes requiring chromatin remodeling in its adaptation to different biological contexts., This research was funded by grants to P. A. L. from Agencia Estatal de Investigación (https://doi.org/10.13039/501100011033-Ministerio) de Ciencia e Innovación-FEDER “Una manera de hacer Europa” (PID2019-105610RB-I00, PID2022-139598OB-I00, RED2018-102801-T), Consejería de Educación de la Junta de Castilla y León-FEDER (CSI264P20, CLC-2017-01). E. N–C was funded by Agencia Estatal de Investigación-MINECO predoctoral fellowship (BES-2017-080543) and EMBO Scientific Exchange Grant ( 9289). A. C-D was funded by a predoctoral contract from Ministerio de Universidades (FPU20/02978 ). E. M-S. was funded by a predoctoral fellowship (CSI004-18) from Consejería de Educación-Junta de Castilla y León-Fondo Social Europeo. Cancer Center Amsterdam and Netherlands Organization for Scientific Research (NWOMiddelgroot project number 91116017) are acknowledged for support of the mass spectrometry infrastructure and Surfsara for computing infrastructure (reference e-infra180166)”., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Nuclear functions regulated by the VRK1 kinase

  • Lazo, Pedro A.
In the nucleus, the VRK1 Ser-Thr kinase is distributed in nucleoplasm and chromatin, where it has different roles. VRK1 expression increases in response to mitogenic signals. VRK1 regulates cyclin D1 expression at G0 exit and facilitates chromosome condensation at the end of G2 and G2/M progression to mitosis. These effects are mediated by the phosphorylation of histone H3 at Thr3 by VRK1, and later in mitosis by haspin. VRK1 regulates the apigenetic patterns of histones in processes requiring chromating remodeling, such as transcription, replication and DNA repair. VRK1 is overexpressed in tumors, facilitating tumor progression and resistance to genotoxic treatments. VRK1 also regulates the organization of Cajal bodies assembled on coilin, which are necessary for the assembly of different types of RNP complexes. VRK1 pathogenic variants cuase defects in Cajal bodies, functionally altering neurons with long axons and leading to neurological diseases, such as amyotrophic laterla sclerosis, spinal muscular atrophy, distal hereditay motor neuropathies and Charcot-Marie-Tooth., This research was funded by grants from Agencia Estatal de Investigación (doi: 10.13039/501100011033)-Ministerio de Ciencia, Innovación y Universidades-FEDER “Una manera de hacer Europa” (PID2019-105610RB-I00, PID2022-139598OB-I00)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Pathogenic effects of Leu200Pro and Arg387His VRK1 protein variants on phosphorylation targets and H4K16 acetylation in distal hereditary motor neuropathy

  • Campos Díaz, Aurora
  • Morejón-García, Patricia
  • Monte-Serrano, Eva
  • Ros-Pardo, David
  • Marcos-Alcalde, Íñigo
  • Gómez-Puertas, Paulino
  • Lazo, Pedro A.
Rare recessive variants in the human VRK1 gene are associated with several motor neuron diseases (MND), such as amyotrophic lateral sclerosis, spinal muscular atrophy, or distal hereditary motor neuropathies (dHMN). A case with dHMN carrying two novel VRK1 gene variants, expressing Leu200Pro (L200P) and Arg387His (R387H) variant proteins, identified that these protein variants are functionally different. The Leu200Pro variant shares with several variants in the catalytic domain the loss of the kinase activity on different substrates, such as histones, p53, or coilin. However, the distal Arg387His variant and the distal Trp375* (W375X) chinese variant, both located at the end of the low complexity C-terminal region and proximal to the termination codon, retain their catalytic activity on some substrates, and mechanistically their functional impairment is different. The L200P variant, as well as most VRK1 pathogenic variants, impairs the phosphorylation of BAF and histone H4K16 acetylation, which are required for DNA attachment to the nuclear envelope and chromatin accessibility to DNA repair mechanisms, respectively. The R387H variant impairs phosphorylation of H2AX, an early step in different types of DNA damage responses. The functional variability of VRK1 protein variants and their different combinations are a likely contributor to the clinical phenotypic heterogeneity of motor neuron and neurological diseases associated with rare VRK1 pathogenic variants., Agencia Estatal de Investigación, PID2019-105610RB-I00, Pedro A. Lazo, PID2022-139598OB-I00, Pedro A. Lazo, RED2018-102801-T, Pedro A. Lazo, RTC-2017-6494-1, Paulino Gómez-Puertas, RTI2018-094434-B-I00, Paulino Gómez-Puertas, Consejería de Educación, Junta de Castilla y León, CSI264P20, Pedro A. Lazo,CLC-2017-01, Pedro A. Lazo, CSI004-18, Eva Monte-Serrano, European JPIAMR network “EPIC-Alliance, Ministerio de Universidades, FPU20/02978, Aurora Campos-Díaz, FPU16/01883, Patricia Morejón-García., Peer reviewed
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Lysine Methyltransferase Inhibitors Impair H4K20me2 and 53BP1 Foci in Response to DNA Damage in Sarcomas, a Synthetic Lethality Strategy

  • Campillo-Marcos, Ignacio|||0000-0002-7657-7127
  • Monte-Serrano, Eva|||0000-0002-0865-2244
  • Navarro-Carrasco, Elena|||0000-0002-1533-8210
  • García-González, Raúl|||0000-0003-4044-2543
  • Lazo, Pedro A.|||0000-0001-8997-3025
Background: Chromatin is dynamically remodeled to adapt to all DNA-related processes, including DNA damage responses (DDR). This adaptation requires DNA and histone epigenetic modifications, which are mediated by several types of enzymes; among them are lysine methyltransferases (KMTs). Methods: KMT inhibitors, chaetocin and tazemetostat (TZM), were used to study their role in the DDR induced by ionizing radiation or doxorubicin in two human sarcoma cells lines. The effect of these KMT inhibitors was tested by the analysis of chromatin epigenetic modifications, H4K16ac and H4K20me2. DDR was monitored by the formation of γH2AX, MDC1, NBS1 and 53BP1 foci, and the induction of apoptosis. Results: Chaetocin and tazemetostat treatments caused a significant increase of H4K16 acetylation, associated with chromatin relaxation, and increased DNA damage, detected by the labeling of free DNA-ends. These inhibitors significantly reduced H4K20 dimethylation levels in response to DNA damage and impaired the recruitment of 53BP1, but not of MDC1 and NBS1, at DNA damaged sites. This modification of epigenetic marks prevents DNA repair by the NHEJ pathway and leads to cell death.